Novaliq GmbH

novaliq.com

Novaliq GmbH
Novaliq is a pharmaceutical company focusing on the development and commercialization of first- and best-in-class ocular therapeutics based on EyeSol®, the first water-free technology worldwide for ophthalmology products.

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us

Events

Related News

Pharma Tech

CAMBREX COMPLETES FIRST PHASE OF $30 MILLION CAPACITY EXPANSION PROJECT IN HIGH POINT, NORTH CAROLINA

Cambrex | September 05, 2022

news image

Cambrex today announced the completion of the first phase of its $30 million investment in its small molecule active pharmaceutical ingredient manufacturing facility in High Point, North Carolina. The newly constructed space adds analytical and chemical development laboratories totaling 30,000 square feet and provides future workspace for 85 analytical and chemical development scientists. These laboratories will support the development of APIs to be manufactured in the facility's curre...

Read More

Business Insights

ALR TECHNOLOGIES COMPLETES DEFINITIVE MANUFACTURING AGREEMENT WITH INFINOVO MEDICAL FOR THE GLUCURVE PET CGM HARDWARE

ALR Technologies | June 30, 2022

news image

ALR Technologies SG Pte. Ltd the diabetes management company, announces the completion of a definitive manufacturing agreement with Infinovo Medical Co. Ltd to manufacture and supply the Continuous Glucose Monitor hardware that will be utilized as part of the ALRT GluCurve Pet CGM. The Manufacturing Agreement gives ALRT the exclusive global rights to distribute the Infinovo CGM hardware for the animal health market, providing long-term production and supply. Subject to the satisfaction of all cl...

Read More

Business Insights

ASYMCHEM ACQUIRES SNAPDRAGON CHEMISTRY

Asymchem | February 14, 2022

news image

Asymchem Laboratories Co., Ltd. a leading CDMO serving the global pharmaceutical and biotech industry, today announced its agreement to acquire Snapdragon Chemistry, Inc., a US-based chemical technology company providing industry-leading expertise in continuous manufacturing and early-stage chemical process development services to the pharmaceutical and fine chemical industries for US $57.94 million. This addition will significantly expand Asymchem's footprint in the US, offering customers a...

Read More

Pharma Tech

COUR PHARMACEUTICALS RECEIVES FDA FAST TRACK DESIGNATION FOR CNP-104 FOR THE TREATMENT OF PRIMARY BILIARY CHOLANGITIS

COUR Pharmaceuticals | January 11, 2022

news image

COUR Pharmaceuticals, a biotechnology company developing novel immune-modifying nanoparticles to treat immune disorders, today announced the U.S. Food and Drug Administration granted Fast Track Designation to the Company's investigational therapy CNP-104 for the treatment of Primary Biliary Cholangitis. CNP-104 aims to reprogram the immune system to address autoimmune causes of PBC. "We are pleased to have received Fast Track Designation for CN...

Read More
news image

Pharma Tech

CAMBREX COMPLETES FIRST PHASE OF $30 MILLION CAPACITY EXPANSION PROJECT IN HIGH POINT, NORTH CAROLINA

Cambrex | September 05, 2022

Cambrex today announced the completion of the first phase of its $30 million investment in its small molecule active pharmaceutical ingredient manufacturing facility in High Point, North Carolina. The newly constructed space adds analytical and chemical development laboratories totaling 30,000 square feet and provides future workspace for 85 analytical and chemical development scientists. These laboratories will support the development of APIs to be manufactured in the facility's curre...

Read More
news image

Business Insights

ALR TECHNOLOGIES COMPLETES DEFINITIVE MANUFACTURING AGREEMENT WITH INFINOVO MEDICAL FOR THE GLUCURVE PET CGM HARDWARE

ALR Technologies | June 30, 2022

ALR Technologies SG Pte. Ltd the diabetes management company, announces the completion of a definitive manufacturing agreement with Infinovo Medical Co. Ltd to manufacture and supply the Continuous Glucose Monitor hardware that will be utilized as part of the ALRT GluCurve Pet CGM. The Manufacturing Agreement gives ALRT the exclusive global rights to distribute the Infinovo CGM hardware for the animal health market, providing long-term production and supply. Subject to the satisfaction of all cl...

Read More
news image

Business Insights

ASYMCHEM ACQUIRES SNAPDRAGON CHEMISTRY

Asymchem | February 14, 2022

Asymchem Laboratories Co., Ltd. a leading CDMO serving the global pharmaceutical and biotech industry, today announced its agreement to acquire Snapdragon Chemistry, Inc., a US-based chemical technology company providing industry-leading expertise in continuous manufacturing and early-stage chemical process development services to the pharmaceutical and fine chemical industries for US $57.94 million. This addition will significantly expand Asymchem's footprint in the US, offering customers a...

Read More
news image

Pharma Tech

COUR PHARMACEUTICALS RECEIVES FDA FAST TRACK DESIGNATION FOR CNP-104 FOR THE TREATMENT OF PRIMARY BILIARY CHOLANGITIS

COUR Pharmaceuticals | January 11, 2022

COUR Pharmaceuticals, a biotechnology company developing novel immune-modifying nanoparticles to treat immune disorders, today announced the U.S. Food and Drug Administration granted Fast Track Designation to the Company's investigational therapy CNP-104 for the treatment of Primary Biliary Cholangitis. CNP-104 aims to reprogram the immune system to address autoimmune causes of PBC. "We are pleased to have received Fast Track Designation for CN...

Read More

Resources

Events

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us